José Antonio Fuentealba

Statistics

Publications

Citations

4.1K

H-Index

Active since

2000

Affiliations

Pontificia Universidad Católica de Chile(Current)

National Medical Research Center of Cardiology

Iuliu Hațieganu University of Medicine and Pharmacy

Karolinska Institutet

McMaster University

José Antonio Fuentealba is an author at Pontificia Universidad Católica de Chile specializing in dopaminergic signaling, neuroscience, and neuropharmacology.

ORCID

Publications per year

2000–2019

Publications

Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 3K citations · Full text

Medicine, Endocrinology, Pharmacology +14

Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 629 citations · Full text

Medicine, Endocrinology, Nephrology +15

Chronic Morphine Treatment and Withdrawal Increase Extracellular Levels of Norepinephrine in the Rat Bed Nucleus of the Stria Terminalis

José Antonio Fuentealba, Marı́a Inés Forray, Katia Gysling · Journal of Neurochemistry · 2000 · 75 citations

Medicine, Neurobiology, Pharmacology +13

PIASγ Represses the Transcriptional Activation Induced by the Nuclear Receptor Nurr1

Danny Galleguillos, Andrea Vecchiola, José Antonio Fuentealba et al. · Journal of Biological Chemistry · 2004 · 67 citations · Full text

Life Sciences, Molecular Biology, Neuroscience +12

Nurr1 regulates RET expression in dopamine neurons of adult rat midbrain

Danny Galleguillos, José Antonio Fuentealba, Luis M. Gómez et al. · Journal of Neurochemistry · 2010 · 47 citations · Full text

Life Sciences, Neurobiology, Neuroscience +14

1–5 of 16